JPMorgan upgraded Ageas (AGESY) to Overweight from Neutral with a price target of EUR 65, up from EUR 55. The European insurers outperformed in 2024, suggesting lower upside potential in 2025, the analyst tells investors in a research note.. However, the firm still sees reasons to remain positive given earnings upgrades and resilience during a period of uncertainty. It adjusted ratings as of a 2025 preview for the European insurance sector.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.